Endocarditis due to Yersinia enterocolitica.
Bonnet
E
E
Archambaud
M
M
Sommabere
A
A
Suc
C
C
Elias
Z
Z
Gallinier
M
M
Massabuau
P
P
Bounhoure
J P
JP
Massip
P
P
D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009428:Netilmicin / Q000627:therapeutic use; D015009:Yersinia Infections / Q000188:drug therapy / Q000382:microbiology*; D015008:Yersinia enterocolitica / Q000187:drug effects / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D005839:Gentamicins; D009428:Netilmicin; D002939:Ciprofloxacin